These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 153333)

  • 1. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.
    Webster GF; Leyden JJ; Norman ME; Nilsson UR
    Infect Immun; 1978 Nov; 22(2):523-9. PubMed ID: 153333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation in acne vulgaris: consumption of complement by comedones.
    Webster GF; Leyden JJ; Nilsson UR
    Infect Immun; 1979 Oct; 26(1):183-6. PubMed ID: 159261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis).
    Puhvel SM; Sakamoto M
    J Invest Dermatol; 1980 Jan; 74(1):36-9. PubMed ID: 6444322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of tetracyclines and erythromycin on complement activation in vitro.
    Ingham E
    Acta Derm Venereol; 1990; 70(6):531-4. PubMed ID: 1981435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.
    Knop J; Bossecker T; Kövary PM
    Arch Dermatol Res; 1982; 274(3-4):267-75. PubMed ID: 6219635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte activating factor released from Propionibacterium acnes. A possible mediator of inflammation in acne vulgaris.
    Pulverer G; Roszkowski W; Beuth HJ; Ko HL; Quie P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):246-51. PubMed ID: 2975904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
    Załuga E
    Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.
    Webster GF; Nilsson UR; McArthur WP
    Inflammation; 1981 Jun; 5(2):165-76. PubMed ID: 7275277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.
    Vowels BR; Yang S; Leyden JJ
    Infect Immun; 1995 Aug; 63(8):3158-65. PubMed ID: 7542639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous visualization of Propionibacterium acnes and Propionibacterium granulosum with immunofluorescence and fluorescence in situ hybridization.
    Jahns AC; Oprica C; Vassilaki I; Golovleva I; Palmer RH; Alexeyev OA
    Anaerobe; 2013 Oct; 23():48-54. PubMed ID: 23896347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acne: a review of immunologic and microbiologic factors.
    Burkhart CG; Burkhart CN; Lehmann PF
    Postgrad Med J; 1999 Jun; 75(884):328-31. PubMed ID: 10435165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients.
    Webster GF; Leyden JJ; Tsai CC; Baehni P; McArthur WP
    J Invest Dermatol; 1980 Jun; 74(6):398-401. PubMed ID: 6445921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
    Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
    Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
    Whiteside JA; Voss JG
    J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of components of the alternative pathway of complement by Propionibacterium acnes cell wall carbohydrate.
    Webster GF; McArthur WP
    J Invest Dermatol; 1982 Sep; 79(3):137-40. PubMed ID: 6809840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
    Basal E; Jain A; Kaushal GP
    J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris.
    Kersey P; Sussman M; Dahl M
    Br J Dermatol; 1980 Dec; 103(6):651-5. PubMed ID: 6450605
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bronnec V; Eilers H; Jahns AC; Omer H; Alexeyev OA
    Front Cell Infect Microbiol; 2021; 11():809792. PubMed ID: 35155271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism.
    Akamatsu H; Niwa Y; Kurokawa I; Masuda R; Nishijima S; Asada Y
    Arch Dermatol Res; 1991; 283(8):524-8. PubMed ID: 1838472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.